Safety and Efficacy Evaluation of 4th Generation Safety-engineered CAR T Cells Targeting Sarcomas

Clinical trial NCT03356782 · RECRUITING

Trial details

NCT number: NCT03356782
Sponsor: Shenzhen Geno-Immune Medical Institute
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Sarcoma Osteoid Sarcoma Ewing Sarcoma

Start date: 2026-06-01
Primary completion: 2029-12-31
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.